Home | Welcome to Contract Pharma   
Last Updated Monday, September 1 2014
Print RSS Feed

Breaking News

Related Searches:
September 16, 2010
Waters Corp. and Hitachi High Technologies America, Inc. (HTA) have entered into an agreement under which HTA will sell Waters’ sample preparation and liquid chromatography (LC) columns to Hitachi users in North America.  Read More »
September 16, 2010
Charles River Laboratories has partnered with Gentronix to offer BlueScreen HC Screening services for the early detection of genotoxicity.  Read More »
September 16, 2010
GlaxoSmithKline and Genmab have decided to refocus the development program for ofatumumab in autoimmune indications.   Read More »
September 16, 2010
Cytori Therapeutics, Inc. has extended and modified its current distribution agreement with GE Healthcare.   Read More »
September 15, 2010
Covance and BML Inc., a Japanese testing company, have opened the CB Trial Laboratory, a new central trial lab in the BML General Lab in Kawagoe City, Saitama Prefecture.  Read More »
September 15, 2010
NicOx S.A. and Merck have expanded their worldwide license agreement following the discovery of a new approach to nitric oxide (NO) donation in their joint research program.  Read More »
September 15, 2010
Ricerca Biosciences’ partnership with Instem, a provider of lab data and information management solutions, has resulted in the development of a new approach aimed at eliminating potential misdosing during drug safety studies.  Read More »
September 15, 2010
BioProcess Technology Consultants has opened a European office in Denmark and appointed Lars Skriver, Ph.D., as senior consultant to lead its operations.   Read More »
September 15, 2010
Life Sciences sales accounted for $335.4 million in the quarter, up 5%.   Read More »
September 14, 2010
Patrick D. Walsh has been named chief executive officer of AAIPharma Services.   Read More »
September 14, 2010
Life Technologies Corp. has finalized license agreements with several companies to provide rights to its CHO (Chinese hamster ovary) cell lines for the production of recombinant proteins used as therapeutic agents and vaccines.  Read More »
September 14, 2010
AMRI has selected a compound from its research program for the treatment of irritable bowel syndrome (IBS) to advance to preclinical testing.  Read More »
September 14, 2010
Genmab and Seattle Genetics (SGI) have entered into an antibody-drug conjugate (ADC) research collaboration, under which Genmab will use SGI's ADC technology with its HuMax-TF antibody targeting the Tissue Factor antigen in solid tumors.  Read More »
September 14, 2010
GenVec, Inc. has achieved the first milestone in its collaboration with Novartis aimed at developing treatments for hearing loss and balance disorders.  Read More »
September 13, 2010
Funds may go toward stock buyback  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On